Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A review of the clinical introduction of 4D particle therapy research concepts.
Knäusl B, Belotti G, Bertholet J, Daartz J, Flampouri S, Hoogeman M, Knopf AC, Lin H, Moerman A, Paganelli C, Rucinski A, Schulte R, Shimizu S, Stützer K, Zhang X, Zhang Y, Czerska K. Knäusl B, et al. Among authors: czerska k. Phys Imaging Radiat Oncol. 2024 Jan 10;29:100535. doi: 10.1016/j.phro.2024.100535. eCollection 2024 Jan. Phys Imaging Radiat Oncol. 2024. PMID: 38298885 Free PMC article. Review.
Clinical necessity of multi-image based (4DMIB) optimization for targets affected by respiratory motion and treated with scanned particle therapy - A comprehensive review.
Knopf AC, Czerska K, Fracchiolla F, Graeff C, Molinelli S, Rinaldi I, Rucincki A, Sterpin E, Stützer K, Trnkova P, Zhang Y, Chang JY, Giap H, Liu W, Schild SE, Simone CB 2nd, Lomax AJ, Meijers A. Knopf AC, et al. Among authors: czerska k. Radiother Oncol. 2022 Apr;169:77-85. doi: 10.1016/j.radonc.2022.02.018. Epub 2022 Feb 18. Radiother Oncol. 2022. PMID: 35189152 Free article. Review.
Optically stimulated luminescence dosimeters for simultaneous measurement of point dose and dose-weighted LET in an adaptive proton therapy workflow.
Bobić M, Christensen JB, Lee H, Choulilitsa E, Czerska K, Togno M, Safai S, Yukihara EG, Winey BA, Lomax AJ, Paganetti H, Albertini F, Nesteruk KP. Bobić M, et al. Among authors: czerska k. Front Oncol. 2024 Jan 8;13:1333039. doi: 10.3389/fonc.2023.1333039. eCollection 2023. Front Oncol. 2024. PMID: 38510267 Free PMC article.
Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS) with a New Pathogenic Variant in TNFRSF1A Gene in a Family of the Adult Male with Renal AA Amyloidosis-Diagnostic and Therapeutic Challenge for Clinicians.
Zegarska J, Wiesik-Szewczyk E, Hryniewiecka E, Wolska-Kusnierz B, Soldacki D, Kacprzak M, Sobczynska-Tomaszewska A, Czerska K, Siedlecki P, Jahnz-Rozyk K, Bernatowska E, Zagozdzon R, Paczek L. Zegarska J, et al. Among authors: czerska k. J Clin Med. 2021 Jan 26;10(3):465. doi: 10.3390/jcm10030465. J Clin Med. 2021. PMID: 33530412 Free PMC article.
A de novo loss-of-function DYNC1H1 mutation in a patient with parkinsonian features and a favourable response to levodopa.
Szczałuba K, Szymańska K, Rydzanicz M, Ciara E, Walczak A, Piekutowska-Abramczuk D, Kosińska J, Jacoszek A, Czerska K, Biernacka A, Laure-Kamionowska M, Gasperowicz P, Pronicka E, Płoski R. Szczałuba K, et al. Among authors: czerska k. Clin Genet. 2018 May;93(5):1107-1108. doi: 10.1111/cge.13133. Epub 2017 Dec 15. Clin Genet. 2018. PMID: 29243232
22 results